Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Non-Current Assets: 2020-2025

Historic Other Non-Current Assets for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $596,000.

  • Arcutis Biotherapeutics' Other Non-Current Assets fell 3.40% to $596,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $596,000, marking a year-over-year decrease of 3.40%. This contributed to the annual value of $617,000 for FY2024, which is 33.30% down from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Other Non-Current Assets stood at $596,000 for Q3 2025, which was down 0.00% from $596,000 recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Other Non-Current Assets registered a high of $1.5 million during Q1 2021, and its lowest value of $596,000 during Q2 2025.
  • Moreover, its 3-year median value for Other Non-Current Assets was $617,000 (2025), whereas its average is $725,182.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 3,180.85% in 2021, then slumped by 33.30% in 2024.
  • Quarterly analysis of 5 years shows Arcutis Biotherapeutics' Other Non-Current Assets stood at $1.5 million in 2021, then fell by 19.97% to $1.2 million in 2022, then dropped by 25.04% to $925,000 in 2023, then plummeted by 33.30% to $617,000 in 2024, then declined by 3.40% to $596,000 in 2025.
  • Its Other Non-Current Assets stands at $596,000 for Q3 2025, versus $596,000 for Q2 2025 and $617,000 for Q1 2025.